PCRX(Pacira BioSciences, Inc.) · 财务报表

PCRX(Pacira BioSciences, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$541.53M$666.82M$674.98M$700.97M$726.41M
毛利润$401.28M$467.53M$490.31M$530.54M$576.66M
营业利润$89.92M$60.02M$87.67M−$73.37M$19.19M
净利润$41.98M$15.91M$41.95M−$99.56M$7.03M
经营现金流$125.72M$145.27M$154.65M$189.39M$151.99M
自由现金流$79.85M$115.20M$139.49M$178.75M$136.66M
摊薄每股收益$0.92$0.34$0.89$-2.15$0.16

Pacira BioSciences, Inc. PCRX